Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Saguaro Biosciences
Canada
- Quebec City
- 05/06/2024
- Seed
- $3,000,000
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success.
ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells.
We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.
- Industry Biotechnology
- Website https://www.saguarobio.com/
- LinkedIn https://www.linkedin.com/company/saguarobio/
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)